Benhaddou-Andaloussi A, Martineau LC, Spoor D, Leduc C, Meddah B, Settaf A, Baddouri K, Haddad PS.

The antidiabetic action of Nigella sativa is mediated by insulin-sensitizing activity in muscle cells and adipocytes.

University of Montreal, R-401 Pavillon Roger Gaudry, 2900 ƒdouard Monpetit, Montreal, Quebec H3T 1J4, Canada. b_andaloussi@yahoo.fr

Nigella sativa seeds, commonly known as black seed or black cumin, are used in North African and Middle Eastern traditional medicine as treatment for diabetes. Despite a widespread use, cellular mechanisms of action are not well understood. The purpose of the project was to confirm the anti-diabetic action of N. sativa in cell-based bioassays and elucidate mechanisms of action. Crude ethanolic extract (200 µg/ml) was applied 20 h to differentiated C2C12 muscle cells and 3T3-L1 adipocytes, two insulin-sensitive cell lines, and effects on insulin-dependent and -independent glucose uptake were assessed by H-deoxyglucose transport assays in the presence or absence of insulin. In muscle cells, N. sativa increased basal glucose uptake by over 50% and insulin-stimulated glucose uptake by 30-50%. This effect was consistently greater than that of 400 mM metformin. In fat cells, basal uptake was increased by over 60%, while stimulated uptake was increased up to 50%. Extract was also applied to differentiating 3T3-L1 pre-adipocytes over a 6 day period to test for acceleration of adipogenesis, a hallmark of the thiazolidinedione class of anti-diabetic drugs. N. sativa increased triglyceride content by three-fold, an effect comparable to 10 µM of rosiglitazone. Western immunoblot analysis of insulin signal transduction pathways revealed that N. sativa increases activity of Akt and ERK MAPK in an insulin-independent manner in both muscle and fat cells. It is concluded that N. sativa mimics and enhances the action of insulin in muscle and fat cells. Furthermore, the effect of N. sativa on adipogenesis suggests that it can affect the expression of genes regulating insulin sensitivity by way of PPAR nuclear receptors. These data are consistent with our recent in-vivo study of the insulin-sensitizing effects of Nigella sativa (Le et al., J. Ethnopharmacology, 2004) and support the ethnopharmacological use of this plant for the management of diabetes. This work was supported by the Canadian Diabetes Association.

 

Back